Edwards Lifesciences announced today that the U.S. Food and Drug Administration (FDA) has approved its transcatheter aortic valve replacement (TAVR) therapy, the SAPIEN 3 platform, for severe aortic ...

Podobas Global Investments announces that its founder, Wojciech Podobas, has increased his ownership stake in Thinca Co., Ltd. (149A.T) to over 15% of the total outstanding shares. The decision ...